Randomized Study of Dual Versus Single Ritonavir-Enhanced Protease Inhibitors for Protease Inhibitor-Experienced Patients with HIV

MLA

Ann C, Collier, et al. “Randomized Study of Dual Versus Single Ritonavir-Enhanced Protease Inhibitors for Protease Inhibitor-Experienced Patients with HIV.” HIV Clinical Trials, vol. 9, Apr. 2008, pp. 91–102. EBSCOhost, https://doi.org/10.1310/hct0902-91.

APA

Ann C, C., Camlin, T., Gerald F, D., Susan H, E., Angela, K., Karin, K., Emanuel N, V., Gary E, P., James F, R., Alex, R., John W, M., & Donald, G. (2008). Randomized Study of Dual Versus Single Ritonavir-Enhanced Protease Inhibitors for Protease Inhibitor-Experienced Patients with HIV. HIV Clinical Trials, 9, 91–102. https://doi.org/10.1310/hct0902-91

Chicago

Ann C, Collier, Tierney Camlin, Downey Gerald F, Eshleman Susan H, Kashuba Angela, Klingman Karin, Vergis Emanuel N, et al. 2008. “Randomized Study of Dual Versus Single Ritonavir-Enhanced Protease Inhibitors for Protease Inhibitor-Experienced Patients with HIV.” HIV Clinical Trials 9 (April): 91–102. doi:10.1310/hct0902-91.